Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial drug efficacy study in Myanmar
ACTRN12614000214639Phase 4Recruiting
- Sponsor
- Defense Services General Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dihydroartemisinin + piperaquine and chloroquine in malaria and Malaria (2 cohorts), sponsored by Defense Services General Hospital. Primary endpoint: Therapeutic failure proportion and efficacy classification. Started Jan 2014; status: recruiting.
02
Drugs
dihydroartemisinin + piperaquinechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12614000214639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000214639.